Summary
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
According to APO Research, The global Oncolytic Virus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oncolytic Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oncolytic Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oncolytic Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oncolytic Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oncolytic Virus include Amgen and Shanghai Sunway Biotech etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oncolytic Virus, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oncolytic Virus, also provides the sales of main regions and countries. Of the upcoming market potential for Oncolytic Virus, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncolytic Virus sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oncolytic Virus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oncolytic Virus sales, projected growth trends, production technology, application and end-user industry.
Oncolytic Virus segment by Company
Amgen
Shanghai Sunway Biotech
Oncolytic Virus segment by Type
Imlygic
Oncorine
Others
Oncolytic Virus segment by Application
Melanoma
Other Cancers
Oncolytic Virus segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oncolytic Virus in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oncolytic Virus manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Oncolytic Virus Market by Type
1.2.1 Global Oncolytic Virus Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Oncolytic Virus Market by Application
1.3.1 Global Oncolytic Virus Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Oncolytic Virus Market Dynamics
2.1 Oncolytic Virus Industry Trends
2.2 Oncolytic Virus Industry Drivers
2.3 Oncolytic Virus Industry Opportunities and Challenges
2.4 Oncolytic Virus Industry Restraints
3 Global Market Growth Prospects
3.1 Global Oncolytic Virus Revenue Estimates and Forecasts (2019-2030)
3.2 Global Oncolytic Virus Revenue by Region
3.2.1 Global Oncolytic Virus Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Oncolytic Virus Revenue by Region (2019-2024)
3.2.3 Global Oncolytic Virus Revenue by Region (2025-2030)
3.2.4 Global Oncolytic Virus Revenue Market Share by Region (2019-2030)
3.3 Global Oncolytic Virus Sales Estimates and Forecasts 2019-2030
3.4 Global Oncolytic Virus Sales by Region
3.4.1 Global Oncolytic Virus Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Oncolytic Virus Sales by Region (2019-2024)
3.4.3 Global Oncolytic Virus Sales by Region (2025-2030)
3.4.4 Global Oncolytic Virus Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Oncolytic Virus Revenue by Manufacturers
4.1.1 Global Oncolytic Virus Revenue by Manufacturers (2019-2024)
4.1.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Oncolytic Virus Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Oncolytic Virus Sales by Manufacturers
4.2.1 Global Oncolytic Virus Sales by Manufacturers (2019-2024)
4.2.2 Global Oncolytic Virus Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Oncolytic Virus Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Oncolytic Virus Sales Price by Manufacturers (2019-2024)
4.4 Global Oncolytic Virus Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Oncolytic Virus Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Oncolytic Virus Manufacturers, Product Type & Application
4.7 Global Oncolytic Virus Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Oncolytic Virus Market CR5 and HHI
4.8.2 2023 Oncolytic Virus Tier 1, Tier 2, and Tier 3
5 Oncolytic Virus Market by Type
5.1 Global Oncolytic Virus Revenue by Type
5.1.1 Global Oncolytic Virus Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Oncolytic Virus Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Oncolytic Virus Revenue Market Share by Type (2019-2030)
5.2 Global Oncolytic Virus Sales by Type
5.2.1 Global Oncolytic Virus Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Oncolytic Virus Sales by Type (2019-2030) & (K Units)
5.2.3 Global Oncolytic Virus Sales Market Share by Type (2019-2030)
5.3 Global Oncolytic Virus Price by Type
6 Oncolytic Virus Market by Application
6.1 Global Oncolytic Virus Revenue by Application
6.1.1 Global Oncolytic Virus Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Oncolytic Virus Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Oncolytic Virus Revenue Market Share by Application (2019-2030)
6.2 Global Oncolytic Virus Sales by Application
6.2.1 Global Oncolytic Virus Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Oncolytic Virus Sales by Application (2019-2030) & (K Units)
6.2.3 Global Oncolytic Virus Sales Market Share by Application (2019-2030)
6.3 Global Oncolytic Virus Price by Application
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Comapny Information
7.1.2 Amgen Business Overview
7.1.3 Amgen Oncolytic Virus Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Amgen Oncolytic Virus Product Portfolio
7.1.5 Amgen Recent Developments
7.2 Shanghai Sunway Biotech
7.2.1 Shanghai Sunway Biotech Comapny Information
7.2.2 Shanghai Sunway Biotech Business Overview
7.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
7.2.5 Shanghai Sunway Biotech Recent Developments
8 North America
8.1 North America Oncolytic Virus Market Size by Type
8.1.1 North America Oncolytic Virus Revenue by Type (2019-2030)
8.1.2 North America Oncolytic Virus Sales by Type (2019-2030)
8.1.3 North America Oncolytic Virus Price by Type (2019-2030)
8.2 North America Oncolytic Virus Market Size by Application
8.2.1 North America Oncolytic Virus Revenue by Application (2019-2030)
8.2.2 North America Oncolytic Virus Sales by Application (2019-2030)
8.2.3 North America Oncolytic Virus Price by Application (2019-2030)
8.3 North America Oncolytic Virus Market Size by Country
8.3.1 North America Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Oncolytic Virus Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Oncolytic Virus Market Size by Type
9.1.1 Europe Oncolytic Virus Revenue by Type (2019-2030)
9.1.2 Europe Oncolytic Virus Sales by Type (2019-2030)
9.1.3 Europe Oncolytic Virus Price by Type (2019-2030)
9.2 Europe Oncolytic Virus Market Size by Application
9.2.1 Europe Oncolytic Virus Revenue by Application (2019-2030)
9.2.2 Europe Oncolytic Virus Sales by Application (2019-2030)
9.2.3 Europe Oncolytic Virus Price by Application (2019-2030)
9.3 Europe Oncolytic Virus Market Size by Country
9.3.1 Europe Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Oncolytic Virus Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Oncolytic Virus Market Size by Type
10.1.1 China Oncolytic Virus Revenue by Type (2019-2030)
10.1.2 China Oncolytic Virus Sales by Type (2019-2030)
10.1.3 China Oncolytic Virus Price by Type (2019-2030)
10.2 China Oncolytic Virus Market Size by Application
10.2.1 China Oncolytic Virus Revenue by Application (2019-2030)
10.2.2 China Oncolytic Virus Sales by Application (2019-2030)
10.2.3 China Oncolytic Virus Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Oncolytic Virus Market Size by Type
11.1.1 Asia Oncolytic Virus Revenue by Type (2019-2030)
11.1.2 Asia Oncolytic Virus Sales by Type (2019-2030)
11.1.3 Asia Oncolytic Virus Price by Type (2019-2030)
11.2 Asia Oncolytic Virus Market Size by Application
11.2.1 Asia Oncolytic Virus Revenue by Application (2019-2030)
11.2.2 Asia Oncolytic Virus Sales by Application (2019-2030)
11.2.3 Asia Oncolytic Virus Price by Application (2019-2030)
11.3 Asia Oncolytic Virus Market Size by Country
11.3.1 Asia Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Oncolytic Virus Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Oncolytic Virus Market Size by Type
12.1.1 MEALA Oncolytic Virus Revenue by Type (2019-2030)
12.1.2 MEALA Oncolytic Virus Sales by Type (2019-2030)
12.1.3 MEALA Oncolytic Virus Price by Type (2019-2030)
12.2 MEALA Oncolytic Virus Market Size by Application
12.2.1 MEALA Oncolytic Virus Revenue by Application (2019-2030)
12.2.2 MEALA Oncolytic Virus Sales by Application (2019-2030)
12.2.3 MEALA Oncolytic Virus Price by Application (2019-2030)
12.3 MEALA Oncolytic Virus Market Size by Country
12.3.1 MEALA Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Oncolytic Virus Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Oncolytic Virus Value Chain Analysis
13.1.1 Oncolytic Virus Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Oncolytic Virus Production Mode & Process
13.2 Oncolytic Virus Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Oncolytic Virus Distributors
13.2.3 Oncolytic Virus Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Oncolytic Virus Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Imlygic Major Manufacturers
Table 3. Oncorine Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Oncolytic Virus Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Melanoma Major Manufacturers
Table 7. Other Cancers Major Manufacturers
Table 8. Oncolytic Virus Industry Trends
Table 9. Oncolytic Virus Industry Drivers
Table 10. Oncolytic Virus Industry Opportunities and Challenges
Table 11. Oncolytic Virus Industry Restraints
Table 12. Global Oncolytic Virus Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Oncolytic Virus Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Oncolytic Virus Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Oncolytic Virus Revenue Market Share by Region (2019-2024)
Table 16. Global Oncolytic Virus Revenue Market Share by Region (2025-2030)
Table 17. Global Oncolytic Virus Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 18. Global Oncolytic Virus Sales by Region (2019-2024) & (K Units)
Table 19. Global Oncolytic Virus Sales by Region (2025-2030) & (K Units)
Table 20. Global Oncolytic Virus Sales Market Share by Region (2019-2024)
Table 21. Global Oncolytic Virus Sales Market Share by Region (2025-2030)
Table 22. Global Oncolytic Virus Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Oncolytic Virus Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Oncolytic Virus Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Oncolytic Virus Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Oncolytic Virus Sales Price (US$/Unit) of Manufacturers (2019-2024)
Table 27. Global Oncolytic Virus Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Oncolytic Virus Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Oncolytic Virus Manufacturers, Product Type & Application
Table 30. Global Oncolytic Virus Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Oncolytic Virus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Oncolytic Virus Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Oncolytic Virus Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Oncolytic Virus Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Oncolytic Virus Revenue Market Share by Type (2019-2024)
Table 37. Global Oncolytic Virus Revenue Market Share by Type (2025-2030)
Table 38. Global Oncolytic Virus Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 39. Global Oncolytic Virus Sales by Type (2019-2024) & (K Units)
Table 40. Global Oncolytic Virus Sales by Type (2025-2030) & (K Units)
Table 41. Global Oncolytic Virus Sales Market Share by Type (2019-2024)
Table 42. Global Oncolytic Virus Sales Market Share by Type (2025-2030)
Table 43. Global Oncolytic Virus Price by Type (2019-2024) & (US$/Unit)
Table 44. Global Oncolytic Virus Price by Type (2025-2030) & (US$/Unit)
Table 45. Global Oncolytic Virus Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Oncolytic Virus Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Oncolytic Virus Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Oncolytic Virus Revenue Market Share by Application (2019-2024)
Table 49. Global Oncolytic Virus Revenue Market Share by Application (2025-2030)
Table 50. Global Oncolytic Virus Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 51. Global Oncolytic Virus Sales by Application (2019-2024) & (K Units)
Table 52. Global Oncolytic Virus Sales by Application (2025-2030) & (K Units)
Table 53. Global Oncolytic Virus Sales Market Share by Application (2019-2024)
Table 54. Global Oncolytic Virus Sales Market Share by Application (2025-2030)
Table 55. Global Oncolytic Virus Price by Application (2019-2024) & (US$/Unit)
Table 56. Global Oncolytic Virus Price by Application (2025-2030) & (US$/Unit)
Table 57. Amgen Company Information
Table 58. Amgen Business Overview
Table 59. Amgen Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Amgen Oncolytic Virus Product Portfolio
Table 61. Amgen Recent Development
Table 62. Shanghai Sunway Biotech Company Information
Table 63. Shanghai Sunway Biotech Business Overview
Table 64. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
Table 66. Shanghai Sunway Biotech Recent Development
Table 67. North America Oncolytic Virus Revenue by Type (2019-2024) & (US$ Million)
Table 68. North America Oncolytic Virus Revenue by Type (2025-2030) & (US$ Million)
Table 69. North America Oncolytic Virus Sales by Type (2019-2024) & (K Units)
Table 70. North America Oncolytic Virus Sales by Type (2025-2030) & (K Units)
Table 71. North America Oncolytic Virus Sales Price by Type (2019-2024) & (US$/Unit)
Table 72. North America Oncolytic Virus Sales Price by Type (2025-2030) & (US$/Unit)
Table 73. North America Oncolytic Virus Revenue by Application (2019-2024) & (US$ Million)
Table 74. North America Oncolytic Virus Revenue by Application (2025-2030) & (US$ Million)
Table 75. North America Oncolytic Virus Sales by Application (2019-2024) & (K Units)
Table 76. North America Oncolytic Virus Sales by Application (2025-2030) & (K Units)
Table 77. North America Oncolytic Virus Sales Price by Application (2019-2024) & (US$/Unit)
Table 78. North America Oncolytic Virus Sales Price by Application (2025-2030) & (US$/Unit)
Table 79. North America Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 80. North America Oncolytic Virus Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 81. North America Oncolytic Virus Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 82. North America Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 83. North America Oncolytic Virus Sales by Country (2019-2024) & (K Units)
Table 84. North America Oncolytic Virus Sales by Country (2025-2030) & (K Units)
Table 85. North America Oncolytic Virus Sales Price by Country (2019-2024) & (US$/Unit)
Table 86. North America Oncolytic Virus Sales Price by Country (2025-2030) & (US$/Unit)
Table 87. US Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 88. Canada Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 89. Europe Oncolytic Virus Revenue by Type (2019-2024) & (US$ Million)
Table 90. Europe Oncolytic Virus Revenue by Type (2025-2030) & (US$ Million)
Table 91. Europe Oncolytic Virus Sales by Type (2019-2024) & (K Units)
Table 92. Europe Oncolytic Virus Sales by Type (2025-2030) & (K Units)
Table 93. Europe Oncolytic Virus Sales Price by Type (2019-2024) & (US$/Unit)
Table 94. Europe Oncolytic Virus Sales Price by Type (2025-2030) & (US$/Unit)
Table 95. Europe Oncolytic Virus Revenue by Application (2019-2024) & (US$ Million)
Table 96. Europe Oncolytic Virus Revenue by Application (2025-2030) & (US$ Million)
Table 97. Europe Oncolytic Virus Sales by Application (2019-2024) & (K Units)
Table 98. Europe Oncolytic Virus Sales by Application (2025-2030) & (K Units)
Table 99. Europe Oncolytic Virus Sales Price by Application (2019-2024) & (US$/Unit)
Table 100. Europe Oncolytic Virus Sales Price by Application (2025-2030) & (US$/Unit)
Table 101. Europe Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 102. Europe Oncolytic Virus Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 103. Europe Oncolytic Virus Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 104. Europe Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 105. Europe Oncolytic Virus Sales by Country (2019-2024) & (K Units)
Table 106. Europe Oncolytic Virus Sales by Country (2025-2030) & (K Units)
Table 107. Europe Oncolytic Virus Sales Price by Country (2019-2024) & (US$/Unit)
Table 108. Europe Oncolytic Virus Sales Price by Country (2025-2030) & (US$/Unit)
Table 109. Germany Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 110. France Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 111. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 112. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 113. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 114. China Oncolytic Virus Revenue by Type (2019-2024) & (US$ Million)
Table 115. China Oncolytic Virus Revenue by Type (2025-2030) & (US$ Million)
Table 116. China Oncolytic Virus Sales by Type (2019-2024) & (K Units)
Table 117. China Oncolytic Virus Sales by Type (2025-2030) & (K Units)
Table 118. China Oncolytic Virus Sales Price by Type (2019-2024) & (US$/Unit)
Table 119. China Oncolytic Virus Sales Price by Type (2025-2030) & (US$/Unit)
Table 120. China Oncolytic Virus Revenue by Application (2019-2024) & (US$ Million)
Table 121. China Oncolytic Virus Revenue by Application (2025-2030) & (US$ Million)
Table 122. China Oncolytic Virus Sales by Application (2019-2024) & (K Units)
Table 123. China Oncolytic Virus Sales by Application (2025-2030) & (K Units)
Table 124. China Oncolytic Virus Sales Price by Application (2019-2024) & (US$/Unit)
Table 125. China Oncolytic Virus Sales Price by Application (2025-2030) & (US$/Unit)
Table 126. Asia Oncolytic Virus Revenue by Type (2019-2024) & (US$ Million)
Table 127. Asia Oncolytic Virus Revenue by Type (2025-2030) & (US$ Million)
Table 128. Asia Oncolytic Virus Sales by Type (2019-2024) & (K Units)
Table 129. Asia Oncolytic Virus Sales by Type (2025-2030) & (K Units)
Table 130. Asia Oncolytic Virus Sales Price by Type (2019-2024) & (US$/Unit)
Table 131. Asia Oncolytic Virus Sales Price by Type (2025-2030) & (US$/Unit)
Table 132. Asia Oncolytic Virus Revenue by Application (2019-2024) & (US$ Million)
Table 133. Asia Oncolytic Virus Revenue by Application (2025-2030) & (US$ Million)
Table 134. Asia Oncolytic Virus Sales by Application (2019-2024) & (K Units)
Table 135. Asia Oncolytic Virus Sales by Application (2025-2030) & (K Units)
Table 136. Asia Oncolytic Virus Sales Price by Application (2019-2024) & (US$/Unit)
Table 137. Asia Oncolytic Virus Sales Price by Application (2025-2030) & (US$/Unit)
Table 138. Asia Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 139. Asia Oncolytic Virus Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 140. Asia Oncolytic Virus Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 141. Asia Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 142. Asia Oncolytic Virus Sales by Country (2019-2024) & (K Units)
Table 143. Asia Oncolytic Virus Sales by Country (2025-2030) & (K Units)
Table 144. Asia Oncolytic Virus Sales Price by Country (2019-2024) & (US$/Unit)
Table 145. Asia Oncolytic Virus Sales Price by Country (2025-2030) & (US$/Unit)
Table 146. Japan Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 147. South Korea Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 148. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 149. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 150. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 151. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 152. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 153. Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 154. MEALA Oncolytic Virus Revenue by Type (2019-2024) & (US$ Million)
Table 155. MEALA Oncolytic Virus Revenue by Type (2025-2030) & (US$ Million)
Table 156. MEALA Oncolytic Virus Sales by Type (2019-2024) & (K Units)
Table 157. MEALA Oncolytic Virus Sales by Type (2025-2030) & (K Units)
Table 158. MEALA Oncolytic Virus Sales Price by Type (2019-2024) & (US$/Unit)
Table 159. MEALA Oncolytic Virus Sales Price by Type (2025-2030) & (US$/Unit)
Table 160. MEALA Oncolytic Virus Revenue by Application (2019-2024) & (US$ Million)
Table 161. MEALA Oncolytic Virus Revenue by Application (2025-2030) & (US$ Million)
Table 162. MEALA Oncolytic Virus Sales by Application (2019-2024) & (K Units)
Table 163. MEALA Oncolytic Virus Sales by Application (2025-2030) & (K Units)
Table 164. MEALA Oncolytic Virus Sales Price by Application (2019-2024) & (US$/Unit)
Table 165. MEALA Oncolytic Virus Sales Price by Application (2025-2030) & (US$/Unit)
Table 166. MEALA Oncolytic Virus Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 167. MEALA Oncolytic Virus Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 168. MEALA Oncolytic Virus Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 169. MEALA Oncolytic Virus Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 170. MEALA Oncolytic Virus Sales by Country (2019-2024) & (K Units)
Table 171. MEALA Oncolytic Virus Sales by Country (2025-2030) & (K Units)
Table 172. MEALA Oncolytic Virus Sales Price by Country (2019-2024) & (US$/Unit)
Table 173. MEALA Oncolytic Virus Sales Price by Country (2025-2030) & (US$/Unit)
Table 174. Mexico Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 175. Brazil Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 176. Israel Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 177. Argentina Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 178. Colombia Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 179. Turkey Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 180. Saudi Arabia Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 181. UAE Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Table 182. Key Raw Materials
Table 183. Raw Materials Key Suppliers
Table 184. Oncolytic Virus Distributors List
Table 185. Oncolytic Virus Customers List
Table 186. Research Programs/Design for This Report
Table 187. Authors List of This Report
Table 188. Secondary Sources
Table 189. Primary Sources
List of Figures
Figure 1. Oncolytic Virus Product Picture
Figure 2. Global Oncolytic Virus Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Oncolytic Virus Market Size Share 2019 VS 2023 VS 2030
Figure 4. Imlygic Picture
Figure 5. Oncorine Picture
Figure 6. Others Picture
Figure 7. Global Oncolytic Virus Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Oncolytic Virus Market Size Share 2019 VS 2023 VS 2030
Figure 9. Melanoma Picture
Figure 10. Other Cancers Picture
Figure 11. Global Oncolytic Virus Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oncolytic Virus Revenue (2019-2030) & (US$ Million)
Figure 13. Global Oncolytic Virus Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global Oncolytic Virus Revenue Market Share by Region: 2023 Versus 2030
Figure 15. Global Oncolytic Virus Revenue Market Share by Region (2019-2030)
Figure 16. Global Oncolytic Virus Sales (2019-2030) & (K Units)
Figure 17. Global Oncolytic Virus Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 18. Global Oncolytic Virus Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Oncolytic Virus Sales YoY (2019-2030) & (K Units)
Figure 20. Europe Oncolytic Virus Sales YoY (2019-2030) & (K Units)
Figure 21. China Oncolytic Virus Sales YoY (2019-2030) & (K Units)
Figure 22. Asia (Excluding China) Oncolytic Virus Sales YoY (2019-2030) & (K Units)
Figure 23. Middle East, Africa and Latin America (Excluding China) Oncolytic Virus Sales YoY (2019-2030) & (K Units)
Figure 24. Global Oncolytic Virus Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 25. Global Oncolytic Virus Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Global Oncolytic Virus Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Oncolytic Virus Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 29. Global Oncolytic Virus Revenue Market Share by Type (2019-2030)
Figure 30. Global Oncolytic Virus Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 31. Global Oncolytic Virus Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 32. Global Oncolytic Virus Sales Market Share by Type (2019-2030)
Figure 33. Global Oncolytic Virus Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 34. Global Oncolytic Virus Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 35. Global Oncolytic Virus Revenue Market Share by Application (2019-2030)
Figure 36. Global Oncolytic Virus Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 37. Global Oncolytic Virus Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 38. Global Oncolytic Virus Sales Market Share by Application (2019-2030)
Figure 39. North America Oncolytic Virus Revenue Share by Type (2019-2030)
Figure 40. North America Oncolytic Virus Sales Share by Type (2019-2030)
Figure 41. North America Oncolytic Virus Revenue Share by Application (2019-2030)
Figure 42. North America Oncolytic Virus Sales Share by Application (2019-2030)
Figure 43. North America Oncolytic Virus Revenue Share by Country (2019-2030)
Figure 44. North America Oncolytic Virus Sales Share by Country (2019-2030)
Figure 45. Europe Oncolytic Virus Revenue Share by Type (2019-2030)
Figure 46. Europe Oncolytic Virus Sales Share by Type (2019-2030)
Figure 47. Europe Oncolytic Virus Revenue Share by Application (2019-2030)
Figure 48. Europe Oncolytic Virus Sales Share by Application (2019-2030)
Figure 49. Europe Oncolytic Virus Revenue Share by Country (2019-2030)
Figure 50. Europe Oncolytic Virus Sales Share by Country (2019-2030)
Figure 51. China Oncolytic Virus Revenue Share by Type (2019-2030)
Figure 52. China Oncolytic Virus Sales Share by Type (2019-2030)
Figure 53. China Oncolytic Virus Revenue Share by Application (2019-2030)
Figure 54. China Oncolytic Virus Sales Share by Application (2019-2030)
Figure 55. Asia Oncolytic Virus Revenue Share by Type (2019-2030)
Figure 56. Asia Oncolytic Virus Sales Share by Type (2019-2030)
Figure 57. Asia Oncolytic Virus Revenue Share by Application (2019-2030)
Figure 58. Asia Oncolytic Virus Sales Share by Application (2019-2030)
Figure 59. Asia Oncolytic Virus Revenue Share by Country (2019-2030)
Figure 60. Asia Oncolytic Virus Sales Share by Country (2019-2030)
Figure 61. MEALA Oncolytic Virus Revenue Share by Type (2019-2030)
Figure 62. MEALA Oncolytic Virus Sales Share by Type (2019-2030)
Figure 63. MEALA Oncolytic Virus Revenue Share by Application (2019-2030)
Figure 64. MEALA Oncolytic Virus Sales Share by Application (2019-2030)
Figure 65. MEALA Oncolytic Virus Revenue Share by Country (2019-2030)
Figure 66. MEALA Oncolytic Virus Sales Share by Country (2019-2030)
Figure 67. Oncolytic Virus Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Oncolytic Virus Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
